DRUG · Mapped RxNorm record
Dapagliflozin
Normalized identity: dapagliflozinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus
NCT01294423
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Dapagliflozin
Normalized identity: dapagliflozinView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEvaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
High Blood Sugarunresolved
Interventions
DapagliflozinDRUG · verified · RxNorm: dapagliflozin
DapagliflozinDRUG · verified · RxNorm: dapagliflozin
PlaceboDRUG
Sponsors & collaborators
AstraZenecalead sponsor
Bristol-Myers Squibbcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01294423 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.